Eleven Biotherapeutics Inc (NASDAQ:EBIO)

2.85
Delayed Data
As of 4:00pm ET
 -0.02 / -0.70%
Today’s Change
2.61
Today|||52-Week Range
14.07
-76.01%
Year-to-Date

Today’s Trading

Previous close2.87
Today’s open2.89
Day’s range2.84 - 2.95
Volume98,908
Average volume (3 months)518,115
Market cap$55.6M
Dividend yield--
Data as of 4:00pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)-66.90%
Earnings growth (this year)+40.17%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+68.14%
P/E ratioNM
Price/Sales77.56
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...0.000.00%
PRANPrana Biotechnology ...0.000.00%
NVETNexvet Biopharma plc-0.03-0.72%
ENZNEnzon Pharmaceutical...+0.21+17.36%
Data as of 4:00pm ET, 07/06/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$2.2M
Annual profit (last year)-$34.2M
Net profit margin-1,522.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial &
Accounting Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers